Preferred conformations of endogenous cannabinoid ligand anandamide

Life Sciences

Volumn 76, Issue 18, 2005, Pages 2053-2069

  Chen, Jian Zhong ^a,b   Han, Xiu Wen ^c   Xie, Xiang Qun ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Anandamide; Cannabinoid; Computer modeling; NMR

Indexed keywords

ANANDAMIDE; CANNABINOID DERIVATIVE; LIGAND; OXYGEN;

ARTICLE; COMPUTER MODEL; CORRELATION ANALYSIS; DRUG CONFORMATION; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PREDICTION; STRUCTURE ANALYSIS; TIME;

EID: 13844276024     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.08.041     Document Type: Article

References (42)

1. V. Abadji, S. Lin, G. Taha, G. Griffin, L.A. Stevenson, R.G. Pertwee, and A. Makriyannis (R)-Methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability Journal of Medicinal Chemistry 37 12 1994 1889 1993
2. I.B. Adams, W. Ryan, M. Singer, R.K. Razdan, D.R. Compton, and B.R. Martin Pharmacological and behavioral evaluation of alkylated anandamide analogs Life Sciences 56 23/24 1995 2041 2048
3. I.B. Adams, W. Ryan, M. Singer, B.F. Thomas, D.R. Compton, R.K. Razdan, and B.R. Martin Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs The Journal of Pharmacology and Experimental Therapeutics 273 31 1995 1172 1181
4. A.S. Arseniev, I.L. Barsukov, V.F. Bystrov, A.L. Lomize, and Y.A. Ovchinnikov 1H NMR study of gramcidin A transmembrane ion channel head to head right handed single stranded helices European Journal of Biochemistry/FEBS 186 1985 168 174
5. J. Barnett-Norris, F. Guarnieri, D.P. Hurst, and P.H. Reggio Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogs using conformational memories Journal of Medicinal Chemistry 41 24 1998 4861 4872
6. C. Bonechi, A. Brizzi, V. Brizzi, M. Francioli, A. Donati, and C. Rossi Conformational analysis of N-arachidonylethanolamide (anandamide) using nuclear magnetic resonance and theoretical calculations Magnetic Resonance in Chemistry 39 8 2001 432 437
7. D.L. Boring, B.A. Berglund, and A.C. Howlett Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors Prostaglandins, Leukotrienes and Essential Fatty Acids 55 3 1996 207 210
8. D. Deutsch, and A. Makriyannis Anandamide amidase inhibitors NIDA Research Monographs 1997 173
9. M.J.S. Dewar, E.G. Zoebisch, E.F. Healy, and J.J.P. Stewart Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model Journal of the American Chemical Society 107 13 1985 3902 3909
10. V. Di Marzo, T. Bisogno, L. De Petrocellis, D. Melck, and B.R. Martin Cannabimimetic fatty acid derivatives: the anandamide family and other 'endocannabinoids' Current Medicinal Chemistry 6 8 1999 721 744
11. W.S. Edgemond, C.J. Hillard, J.R. Falck, C.S. Kearn, and W.B. Campbell Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanol-amide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation Molecular Pharmacology 54 1 1998 180 188
12. E. Fride, and R. Mechoulam Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent European Journal of Biochemistry/FEBS 231 21 1993 313 314
13. E.W. Garbisch Conformations: VI. Vinyl-allylic proton spin couplings Journal of the American Chemical Society 86 24 1964 5561 5564
14. L. Hanus, A. Gopher, S. Almog, and R. Mechoulam Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor Journal of Medicinal Chemistry 36 20 1993 3032 3034
15. R.E. Hurd, and B.K. John Gradient-enhanced proton-detected heteronuclear multiple-quantum coherence spectroscopy Journal of Magnetic Resonance 91 3 1991 648 653
16. H. Kessler, J.W. Bats, C. Griesinger, S. Koll, M. Will, and K. Wagner Peptide conformations: 46. Conformational analysis of a superpotent cytoprotective cyclic somatostatin analog Journal of the American Chemical Society 110 4 1988 1033 1049
17. A. Khanolkar, V. Abadji, G. Taha, K. Abouzid, Z. Meng, S. Lin, and A. Makriyannis Structure-activity relationship of analogs of anandamide, an endogenous ligand for the cannabinoid receptor Journal of Medicinal Chemistry 39 1 1996 45 49
18. A.D. Khanolkar, V. Abadji, S. Lin, W.A.G. Hill, G. Taha, K. Abouzid, Z. Meng, P. Fan, and A. Makriyannis Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand Journal of Medicinal Chemistry 39 22 1996 4515 4519
19. Marat, K., 1997. SPINWORKS Iterative 1D NMR simulation program, University of Manitoba, Department of Chemistry, NMR Laboratory, Winnipeg, Manitoba, Canada R3T 2N2.
20. J.L. Markley, A. Bax, Y. Arata, C.W. Hilbers, R. Kaptein, B.D. Sykes, P.E. Wright, and K. Wüthrich Recommendations for the presentation of NMR structures of proteins and nucleic acids Journal of Biomolecular NMR 12 1998 1 23
21. B.R. Martin, R. Mechoulam, and R.K. Razdan Discovery and characterization of endogenous cannabinoids Life Sciences 65 6 1999 573 595
22. R.G. Pertwee, L.A. Stevenson, and G. Griffin Cross-tolerance between delta-9-tetrahydro-cannabinol and the cannabimimetic agents CP 55,940, WIN 55,212-2 and anandamide British Journal of Pharmacology 110 1993 1483 1490
23. K.V. Pervushin, V.Y. Orekhov, A.I. Popov, L.Y. Musina, and A.S. Arseniev Three-dimensional structure of (1-71)bacterioopsin solubilized in methanol/chloroform and SDS micelles determined by nitrogen-15-proton heteronuclear NMR spectroscopy European Journal of Biochemistry/FEBS 219 1-2 1994 571 583
24. J.C. Pinto, F. Potie, K.C. Rice, D. Boring, M.R. Johnson, D.M. Evans, G.H. Wilken, C.H. Cantrell, and A.C. Howlett Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid Molecular Pharmacology 46 31 1994 516 522
25. A.L. Rabinovich, and P.O. Ripatti On the conformational, physical properties and function of polyunsaturated acyl chains Biochimica et Biophysica Acta 1085 1991 53 56
26. P.H. Reggio Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2&3 2002 143 160
27. P.H. Reggio Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors Current Pharmaceutical Design 9 2003 1607 1633
28. M.R. Rich Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations Biochimica et Biophysica Acta 1178 1993 87 96
29. W. Ryan, J. Wyler, D.R. Compton, B.R. Martin, and R.K. Razan Novel branched chain alkyl anandamide analogs The International Cannabis Research Society Meeting, West Dennis, Massachusetts 1996 74
30. T. Sheskin, L. Hanus, J. Slager, Z. Vogel, and R. Mechoulam Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor Journal Medicinal Chemistry 40 5 1997 659 667
31. R.M. Silverstein, G.C. Bassler, and T.C. Morrill Spectrometric Identification of Organic Compounds fourth edition 1981 John Wiley and Sons New York 209
32. D.J. States, R.A. Haberkorn, and D.J. Ruben A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants Journal of Magnetic Resonance 48 2 1982 286 292
33. SYBYL Molecular modeling software packages 2001 TRIPOS, Associates, Inc St. Louis, MI63144
34. G. Tarzia, A. Duranti, A. Tontini, G. Piersanti, M. Mor, S. Rivara, P.V. Plazzi, C. Park, S. Kathuria, and D. Piomelli Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors Journal of Medicinal Chemistry 46 12 2003 2352 2360
35. B.F. Thomas, I.B. Adams, S.W. Mascarella, B.R. Martin, and R.K. Razdan Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore Journal of Medicinal Chemistry 39 2 1996 471 479
36. W. Tong, E.R. Collantes, W.J. Welsh, B.A. Berglund, and A.C. Howlett Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis Journal of Medicinal Chemistry 41 22 1998 4207 4215
37. K. Varga, K. Lake, B.R. Martin, and G. Kunos Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide European Journal of Biochemistry 278 31 1995 279 283
38. W. Willker, D. Leibfritz, R. Kerssebaum, and W. Bermel Gradient selection in inverse heteronuclear correlation spectroscopy Magnetic Resonance in Chemistry 31 3 1993 287 292
39. M.L. Wise, K. Soderstrom, T.F. Murray, and W.H. Gerwick Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid Experientia 52 1 1996 88 92
40. X.Q. Xie, X.W. Han, J.Z. Chen, Q. Liu, and A. Makriyannis Better understanding of conformational properties of anandamide International Cannabinoid Society Meeting, Acapulco, Mexico 1999 11
41. X.Q. Xie, L.S. Melvin, and A. Makriyannis The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940 The Journal of Biological Chemistry 271 181 1996 10640 10647
42. X.Q. Xie, D.P. Yang, L.S. Melvin, and A. Makriyannis Conformational analysis of the prototype nonclassical cannabinoid CP-47,497, using 2D NMR and computer molecular modeling Journal of Medicinal Chemistry 37 10 1994 1418 1426